ACAD
48.81
+0.99
+2.07%
AEMD
9.99
+0.19
+1.94%
APRI
1.44
+0.01
+0.70%
ARNA
4.04
+0.07
+1.76%
ATEC
1.36
0.00
0.00%
CNAT
4.74
-0.08
-1.66%
CRXM
0.3
0.00
0.00%
CYTX
0.44
+0.01
+2.33%
DXCM
84.65
+0.73
+0.87%
GNMK
8.5
+0.02
+0.24%
HALO
23.34
+0.21
+0.91%
ILMN
219.3
+0.43
+0.20%
INNV
0.155
0.00
0.00%
INO
7.29
+0.08
+1.11%
ISCO
0.043
0.00
0.00%
ISIS
54.93
+1.76
+3.31%
LGND
108.26
+0.48
+0.45%
LPTN
0.27
0.00
+0.15%
MBVX
2.16
+0.21
+10.77%
MEIP
1.56
-0.04
-2.50%
MNOV
3.75
+0.06
+1.63%
MRTX
28.61
+1.11
+4.04%
MSTX
0.447
0.00
-0.0447%
NBIX
50.12
+0.1
+0.20%
NUVA
55.01
+0.08
+0.15%
ONCS
6.06
-0.04
-0.66%
ONVO
3.38
+0.01
+0.30%
OREX
4
+0.05
+1.27%
OTIC
25.77
+0.26
+1.02%
QDEL
20.71
-0.25
-1.19%
RCPT
227.86
+0.38
+0.17%
RGLS
8.2
-0.06
-0.73%
RMD
57.95
+1.83
+3.26%
SCIE
0.018
-0.002
-10.000%
SPHS
0.87
-0.01
-1.1818%
SRNE
20.78
+0.39
+1.91%
TROV
7.88
+0.07
+0.90%
VICL
0.644
+0.014
+2.222%
ZGNX
19.31
0.00
0.00%
ACAD
48.81
+0.99
+2.07%
AEMD
9.99
+0.19
+1.94%
APRI
1.44
+0.01
+0.70%
ARNA
4.04
+0.07
+1.76%
ATEC
1.36
0.00
0.00%
CNAT
4.74
-0.08
-1.66%
CRXM
0.3
0.00
0.00%
CYTX
0.44
+0.01
+2.33%
DXCM
84.65
+0.73
+0.87%
GNMK
8.5
+0.02
+0.24%
HALO
23.34
+0.21
+0.91%
ILMN
219.3
+0.43
+0.20%
INNV
0.155
0.00
0.00%
INO
7.29
+0.08
+1.11%
ISCO
0.043
0.00
0.00%
ISIS
54.93
+1.76
+3.31%
LGND
108.26
+0.48
+0.45%
LPTN
0.27
0.00
+0.15%
MBVX
2.16
+0.21
+10.77%
MEIP
1.56
-0.04
-2.50%
MNOV
3.75
+0.06
+1.63%
MRTX
28.61
+1.11
+4.04%
MSTX
0.447
0.00
-0.0447%
NBIX
50.12
+0.1
+0.20%
NUVA
55.01
+0.08
+0.15%
ONCS
6.06
-0.04
-0.66%
ONVO
3.38
+0.01
+0.30%
OREX
4
+0.05
+1.27%
OTIC
25.77
+0.26
+1.02%
QDEL
20.71
-0.25
-1.19%
RCPT
227.86
+0.38
+0.17%
RGLS
8.2
-0.06
-0.73%
RMD
57.95
+1.83
+3.26%
SCIE
0.018
-0.002
-10.000%
SPHS
0.87
-0.01
-1.1818%
SRNE
20.78
+0.39
+1.91%
TROV
7.88
+0.07
+0.90%
VICL
0.644
+0.014
+2.222%
ZGNX
19.31
0.00
0.00%
Home » Archive by Category

Drug Discovery

SDBN October 26th Event Featuring Trius Therapeutics

October 5, 2010 – 7:47 am

Trius Therapeutics is a great local company which recently had an initial public offering (IPO), quite a feat in this economy. What is the secret to their success? They focus on antibacterials for life threatening …

September 28th Event Sponsored by Halozyme Therapeutics

September 6, 2010 – 11:02 am

We’re going to try something new for the San Diego Biotechnology Network in September. The folks at Halozyme have offered to start hosting events quarterly at their site in Sorrento Valley, and we’ll kick of …

SDBN August 18th Event: The Human Genome 10 Years Later: What Does it Mean for San Diego Biotech?

July 23, 2010 – 4:31 pm

June 2010 marks the 10th anniversary of the sequencing of the human genome. As Francis Collins has pointed out, “we invariably overestimate the short-term impacts of new technologies and underestimate their longer-term effects.” As a …

SDBN July 21st Speed Networking Event Sponsored by Life Technologies

July 1, 2010 – 3:42 pm

Our January Speed Networking event went so well that we promised we’d do it again so that you can meet as many local biotech professionals as possible in one night. How does it work? Check …

San Diego Stem Cell Coalition to Fight ALS: CIRM Update

June 30, 2010 – 1:42 pm

The California Institute for Regenerative Medicine (CIRM) granted a local interdisciplinary research team from UCSD, Salk, and Life Technologies $11.5 million for research aimed at finding a cure for amyotrophic lateral sclerosis (ALS), or Lou …

#SBS10 Day 3 – Smart mice and blowing House, M.D.’s mind: Drug discovery in epigenetics

April 14, 2010 – 7:37 pm

At the afternoon session of the Society for Biomolecular Science in Phoenix, it’s all about epigenetics, the study of heritable changes that don’t involve changes in genetic sequence. Epigenetics explains why identical twins turn out a little different and why even cloned cows will have different coloration patterns.

#SBS10 report: iPS disease models coming of age for neurology

April 14, 2010 – 1:29 pm

I went to a morning session on stem cells on day 2 of the Society for Biomolecular Science meeting in Phoenix, a meeting focused on advancements in drug discovery and screening technology.  After this, it’s …

SBS Meeting report shows strong growth of Pubchem database #SBS10

April 14, 2010 – 8:46 am

At the 2010 Society for Biomolecular Science meeting on Tuesday, Steve Bryant from NIH gave a report on the increasing utility of the NIH Pubchem database for pharma drug screening programs.

SBS Day Two: A Holistic Approach To Drug Discovery #sbs10

April 14, 2010 – 7:11 am

I’m blogging from the Society for Biomolecular Sciences conference in Phoenix, the organizers were kind enough to offer two of us complimentary passes. I was surprised that the sessions were separated into disease area, technique, …

Drug Discovery Channel–Welcome

April 11, 2010 – 3:10 pm

We are launching channels on the San Diego Biotechnology Network, where local scientists and biotechnology professionals will be able to blog and discuss the topic. Our first posts will be from the Society for Biomolecular …